Recruiting

Observational Study

Sponsor:

Fresenius Medical Care North America

Code:

NCT01842776

Conditions

Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 "tracks." Tracks 1 \& 2: Implement use of checklists of activities for staff to complete when patients are admitted to the hospital, and post-hospitalization with emphasis on fluid assessment, nutrition management, patient coaching, and communication between institutions. Track 3: Work with physicians to develop process to individualize post-hospitalization dialysis orders and improve medication reconciliation. Track 4: Use a renal Care Transitions Case Manager to follow patients in the hospital and 30 days post-hospitalization to facilitate care and patient coaching.

Conditions

Renal Disease

Study ID

NCT01842776

Start date

Mar, 2013

Status verified date

Apr, 2013

Completion date

Dec, 2014

Anticipated

Primary completion date

Jun, 2014

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Chronic hemodialysis patients
  • All patients admitted to the hospital during the study period

Exclusion Criteria:

  • Patients <18 years old

Study Design

Enrollment

3300 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • 30-day readmission rate [ Time Frame: Participants will be followed for the duration of each hospital stay and 30 days post-hospitalization, for an expected average of 37 days. ]

Central Contacts and Locations

Central contacts

Locations

Fresenius

Recruiting

Franklin, Tennessee, United States, 37067

Contacts

Rebecca L Wingard, RN, MSN

615-567-4846rebecca.wingard@fmc-na.com

Principal Investigator:

Franklin Maddux, MD, FACP

More Information

Sponsor

Fresenius Medical Care North America

Last update posted

Apr 30, 2013

Last verified

Apr, 2013

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Fresenius Medical Care North America on 2013-04-30.